SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into
Possible Breaches of Fiduciary Duty by the Board of Somaxon Pharmaceuticals,
NEW YORK -- December 11, 2012
Levi & Korsinsky is investigating the Board of Directors of Somaxon
Pharmaceuticals, Inc. (“Somaxon” or the “Company”) (NasdaqCM: SOMX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Pernix Therapeutics Holdings, Inc.
(NYSE MKT: PTX).
Click here to learn more about the investigation:
http://zlk.9nl.com/somaxon-pharmaceuticals-somx/, or call: 877-363-5972. There
is no cost or obligation to you.
Under the terms of the transaction, Somaxon shareholders will receive an
aggregate consideration equal to $25 million in Pernix common stock. The
number of shares of Pernix stock issued will be based on the volume-weighted
average price of Pernix’s common stock in the 30 day period prior to the
merger’s closing, representing a value of between $6.00 and $9.00 per share.
The investigation concerns whether the Somaxon Board of Directors breached
their fiduciary duties to stockholders by failing to adequately shop the
Company before entering into this agreement with Pernix Therapeutics Holdings,
If you own common stock in Somaxon and wish to obtain additional information,
please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
Press spacebar to pause and continue. Press esc to stop.